Shuiying Hu

18PUBLICATIONS
74CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomicsElectrical circuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 27, 2026
Pacific Blue Derivatives of Paclitaxel as Fluorescent Probes of OATP1B-Type Transporters.

Mahesh R Nepal, Yue Xu, Yan Jin

|Dec 30, 2025
OATP2B1 Deficiency Ameliorates Irinotecan-Induced Gastrointestinal Toxicity.

Hanieh Taheri, Peter de Bruijn, Yang Li

|Apr 26, 2025
Determination and Disposition of the Aromatase Inhibitor Exemestane in CYP3A-Deficient Mice.

Hanieh Taheri, Eman Ahmed, Peng Hu

|Mar 10, 2025
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.

Hanieh Taheri, Yang Li, Kevin M Huang

|Aug 29, 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.

Thomas Drabison, Mike Boeckman, Yan Yang

Pageof 3